Mycobacterium Abscessus – Diagnostic and Therapeutic Frontiers in Infection Management

1. Brown-Elliott BA, Wallace RJ. Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev. 2002 Oct;15(4):716–46. Brown-ElliottBA WallaceRJ Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria Clin Microbiol Rev 2002 Oct 15 4 716 46 Search in Google Scholar

2. Gopalaswamy R, Shanmugam S, Mondal R, Subbian S. Of tuberculosis and non-tuberculous mycobacterial infections - a comparative analysis of epidemiology, diagnosis and treatment. J Biomed Sci. 2020 Jun 17;27(1):74. GopalaswamyR ShanmugamS MondalR SubbianS Of tuberculosis and non-tuberculous mycobacterial infections - a comparative analysis of epidemiology, diagnosis and treatment J Biomed Sci 2020 Jun 17 27 1 74 Search in Google Scholar

3. Wassilew N, Hoffmann H, Andrejak C, Lange C. Pulmonary Disease Caused by Non-Tuberculous Mycobacteria. Respir Int Rev Thorac Dis. 2016;91(5):386–402. WassilewN HoffmannH AndrejakC LangeC Pulmonary Disease Caused by Non-Tuberculous Mycobacteria Respir Int Rev Thorac Dis. 2016 91 5 386 402 Search in Google Scholar

4. Daley CL, Iaccarino JM, Lange C, Cambau E, Wallace RJ Jr, Andrejak C, et al. Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline. Clin Infect Dis. 2020 Aug 14;71(4):905–13. DaleyCL IaccarinoJM LangeC CambauE WallaceRJJr AndrejakC Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline Clin Infect Dis 2020 Aug 14 71 4 905 13 Search in Google Scholar

5. Griffith DE, Daley CL. Treatment of Mycobacterium abscessus Pulmonary Disease. Chest. 2022 Jan;161(1):64–75. GriffithDE DaleyCL Treatment of Mycobacterium abscessus Pulmonary Disease Chest 2022 Jan 161 1 64 75 Search in Google Scholar

6. Sharma SK, Upadhyay V. Epidemiology, diagnosis & treatment of non-tuberculous mycobacterial diseases. Indian J Med Res. 2020 Sep;152(3):185. SharmaSK UpadhyayV Epidemiology, diagnosis & treatment of non-tuberculous mycobacterial diseases Indian J Med Res 2020 Sep 152 3 185 Search in Google Scholar

7. Ratnatunga CN, Lutzky VP, Kupz A, Doolan DL, Reid DW, Field M, et al. The Rise of Non-Tuberculosis Mycobacterial Lung Disease. Front Immunol [Internet]. 2020 [cited 2023 Oct 15];11. Available from: https://www.frontiersin.org/articles/10.3389/fimmu.2020.00303 RatnatungaCN LutzkyVP KupzA DoolanDL ReidDW FieldM The Rise of Non-Tuberculosis Mycobacterial Lung Disease Front Immunol [Internet]. 2020 [cited 2023 Oct 15];11. Available from: https://www.frontiersin.org/articles/10.3389/fimmu.2020.00303 Search in Google Scholar

8. Diel R, Jacob J, Lampenius N, Loebinger M, Nienhaus A, Rabe KF, et al. Burden of non-tuberculous mycobacterial pulmonary disease in Germany. Eur Respir J. 2017 Apr;49(4):1602109. DielR JacobJ LampeniusN LoebingerM NienhausA RabeKF Burden of non-tuberculous mycobacterial pulmonary disease in Germany Eur Respir J 2017 Apr 49 4 1602109 Search in Google Scholar

9. Andréjak C, Thomsen VØ, Johansen IS, Riis A, Benfield TL, Duhaut P, et al. Nontuberculous Pulmonary Mycobacteriosis in Denmark. Am J Respir Crit Care Med. 2010 Mar;181(5):514–21. AndréjakC ThomsenVØ JohansenIS RiisA BenfieldTL DuhautP Nontuberculous Pulmonary Mycobacteriosis in Denmark Am J Respir Crit Care Med 2010 Mar 181 5 514 21 Search in Google Scholar

10. Przybylski G, Bukowski J, Kowalska W, Pilaczyńska-Cemel M, Krawiecka D. Trends from the Last Decade with Nontuberculous Mycobacteria Lung Disease (NTM-LD): Clinicians’ Perspectives in Regional Center of Pulmonology in Bydgoszcz, Poland. Pathogens. 2023 Jul 28;12(8):988. PrzybylskiG BukowskiJ KowalskaW Pilaczyńska-CemelM KrawieckaD Trends from the Last Decade with Nontuberculous Mycobacteria Lung Disease (NTM-LD): Clinicians’ Perspectives in Regional Center of Pulmonology in Bydgoszcz, Poland Pathogens 2023 Jul 28 12 8 988 Search in Google Scholar

11. Lee MR, Sheng WH, Hung CC, Yu CJ, Lee LN, Hsueh PR. Mycobacterium abscessus Complex Infections in Humans. Emerg Infect Dis. 2015 Sep;21(9):1638–46. LeeMR ShengWH HungCC YuCJ LeeLN HsuehPR Mycobacterium abscessus Complex Infections in Humans Emerg Infect Dis 2015 Sep 21 9 1638 46 Search in Google Scholar

12. Moore M, Frerichs JB. An unusual acid-fast infection of the knee with subcutaneous, abscess-like lesions of the gluteal region; report of a case with a study of the organism, Mycobacterium abscessus, n. sp. J Invest Dermatol. 1953 Feb;20(2):133–69. MooreM FrerichsJB An unusual acid-fast infection of the knee with subcutaneous, abscess-like lesions of the gluteal region; report of a case with a study of the organism, Mycobacterium abscessus, n. sp J Invest Dermatol. 1953 Feb 20 2 133 69 Search in Google Scholar

13. Medjahed H, Gaillard JL, Reyrat JM. Mycobacterium abscessus: a new player in the mycobacterial field. Trends Microbiol. 2010 Mar 1;18(3):117–23. MedjahedH GaillardJL ReyratJM Mycobacterium abscessus: a new player in the mycobacterial field Trends Microbiol 2010 Mar 1 18 3 117 23 Search in Google Scholar

14. Boudehen YM, Kremer L. Mycobacterium abscessus. Trends Microbiol. 2021 Oct 1;29(10):951–2. BoudehenYM KremerL Mycobacterium abscessus Trends Microbiol 2021 Oct 1 29 10 951 2 Search in Google Scholar

15. Nessar R, Cambau E, Reyrat JM, Murray A, Gicquel B. Mycobacterium abscessus: a new antibiotic nightmare. J Antimicrob Chemother. 2012 Apr;67(4):810–8. NessarR CambauE ReyratJM MurrayA GicquelB Mycobacterium abscessus: a new antibiotic nightmare J Antimicrob Chemother 2012 Apr 67 4 810 8 Search in Google Scholar

16. Parmar S, Tocheva EI. The cell envelope of Mycobacterium abscessus and its role in pathogenesis. PLOS Pathog. 2023 5;19(5):e1011318. ParmarS TochevaEI The cell envelope of Mycobacterium abscessus and its role in pathogenesis PLOS Pathog. 2023 5 19 5 e1011318 Search in Google Scholar

17. Roux AL, Viljoen A, Bah A, Simeone R, Bernut A, Laencina L, et al. The distinct fate of smooth and rough Mycobacterium abscessus variants inside macrophages. Open Biol. 2016 Nov;6(11): 160185. RouxAL ViljoenA BahA SimeoneR BernutA LaencinaL The distinct fate of smooth and rough Mycobacterium abscessus variants inside macrophages Open Biol 2016 Nov 6 11 160185 Search in Google Scholar

18. Jönsson B, Ridell M, Wold AE. Phagocytosis and cytokine response to rough and smooth colony variants of Mycobacterium abscessus by human peripheral blood mononuclear cells. APMIS. 2013;121(1):45–55. JönssonB RidellM WoldAE Phagocytosis and cytokine response to rough and smooth colony variants of Mycobacterium abscessus by human peripheral blood mononuclear cells APMIS. 2013 121 1 45 55 Search in Google Scholar

19. Rüger K, Hampel A, Billig S, Rücker N, Suerbaum S, Bange FC. Characterization of rough and smooth morphotypes of Mycobacterium abscessus isolates from clinical specimens. J Clin Microbiol. 2014 Jan;52(1):244–50. RügerK HampelA BilligS RückerN SuerbaumS BangeFC Characterization of rough and smooth morphotypes of Mycobacterium abscessus isolates from clinical specimens J Clin Microbiol 2014 Jan 52 1 244 50 Search in Google Scholar

20. Degiacomi G, Sammartino JC, Chiarelli LR, Riabova O, Makarov V, Pasca MR. Mycobacterium abscessus, an Emerging and Worrisome Pathogen among Cystic Fibrosis Patients. Int J Mol Sci. 2019 Nov 22;20(23):5868. DegiacomiG SammartinoJC ChiarelliLR RiabovaO MakarovV PascaMR Mycobacterium abscessus, an Emerging and Worrisome Pathogen among Cystic Fibrosis Patients Int J Mol Sci 2019 Nov 22 20 23 5868 Search in Google Scholar

21. Harris KA, Kenna DTD. Mycobacterium abscessus infection in cystic fibrosis: molecular typing and clinical outcomes. J Med Microbiol. 2014;63(10):1241–6. HarrisKA KennaDTD Mycobacterium abscessus infection in cystic fibrosis: molecular typing and clinical outcomes J Med Microbiol. 2014 63 10 1241 6 Search in Google Scholar

22. López-Valdez JA, Aguilar-Alonso LA, Gándara-Quezada V, Ruiz-Rico GE, Ávila-Soledad JM, Reyes AA, et al. Cystic fibrosis: current concepts. Bol Méd Hosp Infant México [Internet]. 2021 [cited 2023 Sep 27];78(6). Available from: https://www.bmhim.com/frame_esp.php?id=279 López-ValdezJA Aguilar-AlonsoLA Gándara-QuezadaV Ruiz-RicoGE Ávila-SoledadJM ReyesAA Cystic fibrosis: current concepts Bol Méd Hosp Infant México [Internet]. 2021 [cited 2023 Sep 27];78(6). Available from: https://www.bmhim.com/frame_esp.php?id=279 Search in Google Scholar

23. Recchia D, Stelitano G, Stamilla A, Gutierrez DL, Degiacomi G, Chiarelli LR, et al. Mycobacterium abscessus Infections in Cystic Fibrosis Individuals: A Review on Therapeutic Options. Int J Mol Sci. 2023 Feb 27;24(5):4635. RecchiaD StelitanoG StamillaA GutierrezDL DegiacomiG ChiarelliLR Mycobacterium abscessus Infections in Cystic Fibrosis Individuals: A Review on Therapeutic Options Int J Mol Sci 2023 Feb 27 24 5 4635 Search in Google Scholar

24. Gulani A, Weiler T. Genetics, Autosomal Recessive. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 [cited 2023 Nov 13]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK546620/ GulaniA WeilerT Genetics, Autosomal Recessive In: StatPearls [Internet] Treasure Island (FL) StatPearls Publishing 2023 [cited 2023 Nov 13]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK546620/ Search in Google Scholar

25. Yu E, Sharma S. Cystic Fibrosis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 [cited 2023 Sep 29]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK493206/ YuE SharmaS Cystic Fibrosis In: StatPearls [Internet] Treasure Island (FL) StatPearls Publishing 2023 [cited 2023 Sep 29]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK493206/ Search in Google Scholar

26. Bell SC, Mall MA, Gutierrez H, Macek M, Madge S, Davies JC, et al. The future of cystic fibrosis care: a global perspective. Lancet Respir Med. 2020 Jan;8(1):65–124. BellSC MallMA GutierrezH MacekM MadgeS DaviesJC The future of cystic fibrosis care: a global perspective Lancet Respir Med 2020 Jan 8 1 65 124 Search in Google Scholar

27. Cystic Fibrosis in Children | Symptoms, Diagnosis & Treatment [Internet]. [cited 2023 Oct 16]. Available from: https://www.cincinnatichildrens.org/health/c/cystic-fibrosis Cystic Fibrosis in Children | Symptoms, Diagnosis & Treatment [Internet] [cited 2023 Oct 16]. Available from: https://www.cincinnatichildrens.org/health/c/cystic-fibrosis Search in Google Scholar

28. VanDevanter DR, Kahle JS, O’Sullivan AK, Sikirica S, Hodgkins PS. Cystic fibrosis in young children: A review of disease manifestation, progression, and response to early treatment. J Cyst Fibros. 2016 Mar 1;15(2):147–57. VanDevanterDR KahleJS O’SullivanAK SikiricaS HodgkinsPS Cystic fibrosis in young children: A review of disease manifestation, progression, and response to early treatment J Cyst Fibros 2016 Mar 1 15 2 147 57 Search in Google Scholar

29. Surette MG. The Cystic Fibrosis Lung Microbiome. Ann Am Thorac Soc. 2014 Jan;11(Supplement 1):S61–5. SuretteMG The Cystic Fibrosis Lung Microbiome Ann Am Thorac Soc 2014 Jan 11 Supplement 1 S61 5 Search in Google Scholar

30. Brugha R, Spencer H. Mycobacterium abscessus in cystic fibrosis. Science. 2021 Apr 30;372(6541): 465–6. BrughaR SpencerH Mycobacterium abscessus in cystic fibrosis Science 2021 Apr 30 372 6541 465 6 Search in Google Scholar

31. Olivier KN, Weber DJ, Wallace RJ, Faiz AR, Lee JH, Zhang Y, et al. Nontuberculous Mycobacteria. Am J Respir Crit Care Med. 2003 Mar 15;167(6):828–34. OlivierKN WeberDJ WallaceRJ FaizAR LeeJH ZhangY Nontuberculous Mycobacteria Am J Respir Crit Care Med 2003 Mar 15 167 6 828 34 Search in Google Scholar

32. Richard M, Gutiérrez AV, Kremer L. Dissecting erm(41)-Mediated Macrolide-Inducible Resistance in Mycobacterium abscessus. Antimicrob Agents Chemother. 2020 Jan 27;64(2):e01879–19. RichardM GutiérrezAV KremerL Dissecting erm(41)-Mediated Macrolide-Inducible Resistance in Mycobacterium abscessus Antimicrob Agents Chemother 2020 Jan 27 64 2 e01879 19 Search in Google Scholar

33. Scotet V, L’Hostis C, Férec C. The Changing Epidemiology of Cystic Fibrosis: Incidence, Survival and Impact of the CFTR Gene Discovery. Genes. 2020 May 26;11(6):589. ScotetV L’HostisC FérecC The Changing Epidemiology of Cystic Fibrosis: Incidence, Survival and Impact of the CFTR Gene Discovery Genes 2020 May 26 11 6 589 Search in Google Scholar

34. Daley CL, Winthrop KL. Mycobacterium avium Complex: Addressing Gaps in Diagnosis and Management. J Infect Dis. 2020 Sep 15;222(Suppl 4):S199–211. DaleyCL WinthropKL Mycobacterium avium Complex: Addressing Gaps in Diagnosis and Management J Infect Dis 2020 Sep 15 222 Suppl 4 S199 211 Search in Google Scholar

35. Haworth CS, Banks J, Capstick T, Fisher AJ, Gorsuch T, Laurenson IF, et al. British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD). Thorax. 2017 Nov;72(Suppl 2):ii1–64. HaworthCS BanksJ CapstickT FisherAJ GorsuchT LaurensonIF British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) Thorax 2017 Nov 72 Suppl 2 ii1 64 Search in Google Scholar

36. Haworth CS, Banks J, Capstick T, Fisher AJ, Gorsuch T, Laurenson IF, et al. British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD). Thorax. 2017 Nov 1;72(Suppl 2):ii1–64. HaworthCS BanksJ CapstickT FisherAJ GorsuchT LaurensonIF British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) Thorax 2017 Nov 1 72 Suppl 2 ii1 64 Search in Google Scholar

37. Rose SJ, Neville ME, Gupta R, Bermudez LE. Delivery of aerosolized liposomal amikacin as a novel approach for the treatment of nontuberculous mycobacteria in an experimental model of pulmonary infection. PloS One. 2014;9(9):e108703. RoseSJ NevilleME GuptaR BermudezLE Delivery of aerosolized liposomal amikacin as a novel approach for the treatment of nontuberculous mycobacteria in an experimental model of pulmonary infection PloS One. 2014 9 9 e108703 Search in Google Scholar

38. Kang N, Jeon K, Kim H, Kwon OJ, Huh HJ, Lee NY, et al. Outcomes of Inhaled Amikacin-Containing Multidrug Regimens for Mycobacterium abscessus Pulmonary Disease. Chest. 2021 Aug 1;160(2):436–45. KangN JeonK KimH KwonOJ HuhHJ LeeNY Outcomes of Inhaled Amikacin-Containing Multidrug Regimens for Mycobacterium abscessus Pulmonary Disease Chest 2021 Aug 1 160 2 436 45 Search in Google Scholar

39. Rominski A, Selchow P, Becker K, Brülle JK, Dal Molin M, Sander P. Elucidation of Mycobacterium abscessus aminoglycoside and capreomycin resistance by targeted deletion of three putative resistance genes. J Antimicrob Chemother. 2017 Aug 1;72(8):2191–200. RominskiA SelchowP BeckerK BrülleJK Dal MolinM SanderP Elucidation of Mycobacterium abscessus aminoglycoside and capreomycin resistance by targeted deletion of three putative resistance genes J Antimicrob Chemother 2017 Aug 1 72 8 2191 200 Search in Google Scholar

40. Caballero AR, Marquart ME, O’Callaghan RJ, Thibodeaux BA, Johnston KH, Dajcs JJ. Effectiveness of fluoroquinolones against Mycobacterium abscessus in vivo. Curr Eye Res. 2006 Jan; 31(1):23–9. CaballeroAR MarquartME O’CallaghanRJ ThibodeauxBA JohnstonKH DajcsJJ Effectiveness of fluoroquinolones against Mycobacterium abscessus in vivo Curr Eye Res 2006 Jan 31 1 23 9 Search in Google Scholar

41. Jafri HS, McCracken GH. Fluoroquinolones in Paediatrics. Drugs. 1999 Oct 1;58(2):43–8. JafriHS McCrackenGH Fluoroquinolones in Paediatrics Drugs 1999 Oct 1 58 2 43 8 Search in Google Scholar

42. Sabin AP, Ferrieri P, Kline S. Mycobacterium abscessus Complex Infections in Children: A Review. Curr Infect Dis Rep. 2017 Nov;19:46. SabinAP FerrieriP KlineS Mycobacterium abscessus Complex Infections in Children: A Review Curr Infect Dis Rep 2017 Nov 19 46 Search in Google Scholar

43. Anderson MW, Schrijver I. Next Generation DNA Sequencing and the Future of Genomic Medicine. Genes. 2010 May 25;1(1):38–69. AndersonMW SchrijverI Next Generation DNA Sequencing and the Future of Genomic Medicine Genes 2010 May 25 1 1 38 69 Search in Google Scholar

44. Gasperskaja E, Kučinskas V. The most common technologies and tools for functional genome analysis. Acta Medica Litu. 2017;24(1):1–11. GasperskajaE KučinskasV The most common technologies and tools for functional genome analysis Acta Medica Litu. 2017 24 1 1 11 Search in Google Scholar

45. Gautam SS, KC R, Leong KW, Mac Aogáin M, O’Toole RF. A step-by-step beginner’s protocol for whole genome sequencing of human bacterial pathogens. J Biol Methods. 2019 Mar 15;6(1):e110. GautamSS KCR LeongKW Mac AogáinM O’TooleRF A step-by-step beginner’s protocol for whole genome sequencing of human bacterial pathogens J Biol Methods 2019 Mar 15 6 1 e110 Search in Google Scholar

46. Lewin A, Kamal E, Semmler T, Winter K, Kaiser S, Schäfer H, et al. Genetic diversification of persistent Mycobacterium abscessus within cystic fibrosis patients. Virulence. 2021 Dec 31;12(1):2415–29. LewinA KamalE SemmlerT WinterK KaiserS SchäferH Genetic diversification of persistent Mycobacterium abscessus within cystic fibrosis patients Virulence 2021 Dec 31 12 1 2415 29 Search in Google Scholar

47. Austin-Tse CA, Jobanputra V, Perry DL, Bick D, Taft RJ, Venner E, et al. Best practices for the interpretation and reporting of clinical whole genome sequencing. Npj Genomic Med. 2022 Apr 8;7(1):1–13. Austin-TseCA JobanputraV PerryDL BickD TaftRJ VennerE Best practices for the interpretation and reporting of clinical whole genome sequencing Npj Genomic Med 2022 Apr 8 7 1 1 13 Search in Google Scholar

48. Dohal M, Porvaznik I, Kusnir P, Mokry J. Whole-Genome Sequencing in Relation to Resistance of. Acta Medica Martiniana. 2019 Apr 1;19(1):12–21. DohalM PorvaznikI KusnirP MokryJ Whole-Genome Sequencing in Relation to Resistance of Acta Medica Martiniana 2019 Apr 1 19 1 12 21 Search in Google Scholar

49. Pinto ACSM, De Pierri CR, Evangelista AG, Gomes AS de LPB, Luciano FB. Deoxynivalenol: Toxicology, Degradation by Bacteria, and Phylogenetic Analysis. Toxins. 2022 Feb;14(2):90. PintoACSM De PierriCR EvangelistaAG Gomes AS deLPB LucianoFB Deoxynivalenol: Toxicology, Degradation by Bacteria, and Phylogenetic Analysis Toxins 2022 Feb 14 2 90 Search in Google Scholar

50. Hatherell HA, Colijn C, Stagg HR, Jackson C, Winter JR, Abubakar I. Interpreting whole genome sequencing for investigating tuberculosis transmission: a systematic review. BMC Med. 2016 Mar 23;14:21. HatherellHA ColijnC StaggHR JacksonC WinterJR AbubakarI Interpreting whole genome sequencing for investigating tuberculosis transmission: a systematic review BMC Med 2016 Mar 23 14 21 Search in Google Scholar

51. Köser CU, Ellington MJ, Peacock SJ. Whole-genome sequencing to control antimicrobial resistance. Trends Genet. 2014 Sep 1;30(9):401–7. KöserCU EllingtonMJ PeacockSJ Whole-genome sequencing to control antimicrobial resistance Trends Genet 2014 Sep 1 30 9 401 7 Search in Google Scholar

52. Parcell BJ, Gillespie SH, Pettigrew KA, Holden MTG. Clinical perspectives in integrating whole-genome sequencing into the investigation of healthcare and public health outbreaks – hype or help? J Hosp Infect. 2021 Mar;109:1–9. ParcellBJ GillespieSH PettigrewKA HoldenMTG Clinical perspectives in integrating whole-genome sequencing into the investigation of healthcare and public health outbreaks – hype or help? J Hosp Infect 2021 Mar 109 1 9 Search in Google Scholar

53. Dohal M, Porvaznik I, Solovic I, Mokry J. Whole Genome Sequencing in the Management of Non-Tuberculous Mycobacterial Infections. Microorganisms. 2021 Oct 27;9(11):2237. DohalM PorvaznikI SolovicI MokryJ Whole Genome Sequencing in the Management of Non-Tuberculous Mycobacterial Infections Microorganisms 2021 Oct 27 9 11 2237 Search in Google Scholar